Yen's strength a two-edged sword for Dainippon Sumitomo
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has become the latest major Japanese pharma company to revise its financial guidance as part of its first-half results, prompted by the seemingly unstoppable appreciation of the yen.